Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544112 · ClinicalTrials.gov registry record
Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 390
- Enrollment target
NCT03544112 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 390 participants.
The verdict
NCT03544112 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 390 participants
- Enrollment target
Study Summary
The purpose of this study is to learn what resources are needed to improve outcomes for patients with opioid use disorder. The study will look at how patients engage in treatment and the decisions that patients and providers make regarding treatment, specifically buprenorphine treatment, for opioid use disorder. The aims of this study are: 1. To evaluate using mixed methods the feasibility and acceptability of OUD screening, ED-initiated BUP, and referral. 2. Over the course of the study and as XR-BUP is added to hospital formularies, to estimate the percentage and confidence intervals of patients assessed, treated, and engaged in treatment at Day 30. This will be a three-site study employing a multi-faceted approach to facilitate clinical protocol implementation and to assess feasibility, acceptability, and impact. Investigators will develop, introduce and update site-specific ED clinical protocols and implementation plans for OUD screening, ED-initiated BUP, and referral for treatment. A participatory action research approach will be utilized along with mixed methods incorporating data derived from: * Medical record and administrative data abstraction, * Research assessments involving patients who are eligible for and willing to receive ED-initiated BUP (including both those who do, and do not, receive BUP); these assessments will document the index ED visit and the 30th day after the index ED visit, * Qualitative interviews, focus groups, and quantitative assessments involving providers and staff, patients, and other stakeholders.
Interventions
- BEHAVIORAL Employ a multifaceted approach to facilitate clinical protocol implementation
- DRUG Initiate BUP (SL-BUP or XR-BUP) in the ED
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-05-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03544112
The ClinicalTrials.gov registry entry for NCT03544112 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Employ a multifaceted approach to facilitate clinical protocol implementation is the first listed.
NCT03544112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03544112 about?
NCT03544112 is a clinical study titled "Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder". The purpose of this study is to learn what resources are needed to improve outcomes for patients with opioid use disorder. The study will look at how patients engage in treatment and the decisions that patients and providers make regarding treatment, specifically buprenorphine treatment, for opioid ...
What is the current status of trial NCT03544112?
This trial is currently completed. The enrollment target is 390 participants. The study started on 2018-06-11. Estimated completion is 2019-05-29.
What interventions are being tested in trial NCT03544112?
The interventions under investigation include: Employ a multifaceted approach to facilitate clinical protocol implementation (BEHAVIORAL), Initiate BUP (SL-BUP or XR-BUP) in the ED (DRUG).
Who is sponsoring clinical trial NCT03544112?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.